Lack of efficacy of Doxil® in TNF-α-based isolated limb perfusion in sarcoma-bearing rats

British Journal of Cancer

Volumn 90, Issue 9, 2004, Pages 1830-1832

  Ten Hagen, T L M ^a   Hoving, S ^a   Ambagtsheer, G ^a   Van Tiel, S T ^a   Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Doxil ; Isolated limb perfusion; Rat; Sarcoma; Tumour necrosis factor alpha

Indexed keywords

DOXORUBICIN; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; LIMB PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DISEASE MODELS, ANIMAL; DOXORUBICIN; HINDLIMB; HUMANS; MALE; ORGAN CULTURE TECHNIQUES; RATS; SARCOMA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2642570969     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601688     Document Type: Article

References (14)

1. Abolhoda A, Brooks A, Nawata S, Kaneda Y, Cheng H, Burt ME (1997) Isolated lung perfusion with doxorubicin prolongs survival in a rodent model of pulmonary metastases. Ann Thorac Surg 64: 181-184
2. de Wilt JHW, Manusama ER, van Tiel ST, Van Ijken MGA, ten Hagen TLM, Eggermont AMM (1999) Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. Br J Cancer 80: 161-166
3. Di Filippo F, Rossi CR, Vaglini M, Azzarelli A, Anza M, Santinami M, Lise M, Cavaliere F, Giannarelli D, Quagliuolo V, Vecchiato A, Deraco M, Garinei R, Foletto M, Botti C, Cavaliere R (1999) Hyperthermic antiblastic perfusion with alpha tumor necrosis factor and doxorubicin for the treatment of soft tissue limb sarcoma in candidates for amputation: results of a phase I study. J Immunother 22: 407-414
4. Eggermont AMM, Schraffordt Koops H, Lienard D, Kroon BBR, Van Geel AN, Hoekstra HJ, Lejeune FJ (1996) Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 14: 2653-2665
5. Gabizon A, Shmeeda H, Barenholz Y (2003) Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet 42: 419-436
6. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612
7. Jain RK, Stock RJ, Chary SR, Rueter M (1990) Convection and diffusion measurements using fluorescence recovery after photobleaching and video image analysis: in vitro calibration and assessment. Microvasc Res 39: 77-93
8. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10: 52-60
9. Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS, Cullis PR, Bally MB (1989) Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 49: 5922-5930
10. Rossi CR, Vecchiato A, Da Pian PP, Nitti D, Lise M, Melanotte PL, Turra S, Vigliani F (1992) Adriamycin in hyperthermic perfusion for advanced limb sarcomas. Ann Oncol 3(Suppl 2): S111-S113
11. ten Hagen TLM, Van Der Veen AH, Nooijen PTGA, van Tiel ST, Seynhaeve ALB, Eggermont AMM (2000) Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats. Int J Cancer 87: 829-837
12. Van Der Veen AH, de Wilt JHW, Eggermont AMM, van Tiel ST, Seynhaeve ALB, ten Hagen TLM (2000) TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects. Br J Cancer 82: 973-980
13. Weksler B, Lenert J, Ng B, Burt M (1994) Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg 107: 50-54
14. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double JA, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 77: 1-10